Check out our FREE go-to-market masterclass with Ankita Mehta and Soumya Dash.
Timestamps:
4:19 - Being an immigrant and being an entrepreneur
7:23 - Convincing your boss to help you start a startup
10:30 - What are chronic wounds?
16:10 - Making personalized therapies affordable
24:00 - The long development cycles in biotech
About Priyanka Dutta Passecker:
Priyanka Dutta Passecker is the co-founder and CEO of Healiva, a biotech startup using advanced cell therapy to treat acute and chronic wounds. She holds a PhD in Neuroscience from Trinity College Dublin and worked for companies like UCB Pharma, Axol Bioscience Ltd and Bioseutica before starting Healiva in 2020.
2-3% of the elderly suffer from painful venous/arterial leg ulcers and nearly 25% of diabetics may develop diabetic foot ulcers in their lifetimes. This burden is borne by healthcare systems, which spend 2% of their budgets on wound management. Worst of all, about 60% of chronic wounds remain unhealed. That’s why Healiva is such a game changer: they use 3 non-virus-based enzymes from codfish pancreas, which, due to their provenance, are quite stable at room temperature, and therefore can be stored in a liquid form and used as a spray. They’re currently getting ready for pre-clinical studies to prove the safety and efficacy of their product.
The cover portrait was edited by www.smartportrait.io.
Don’t forget to give us a follow on Twitter, Instagram, Facebook and Linkedin, so you can always stay up to date with our latest initiatives. That way, there’s no excuse for missing out on live shows, weekly giveaways or founders' dinners.
